-
1
-
-
0029024716
-
Irritable bowel syndrome in a community: Symptom subgroups, risk factors, and health care utilization
-
Talley NJ, Zinsmeister AR, Melton LJ 3rd: Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 142:76-83, 1995
-
(1995)
Am J Epidemiol
, vol.142
, pp. 76-83
-
-
Talley, N.J.1
Zinsmeister, A.R.2
Melton III, L.J.3
-
2
-
-
0035859198
-
The irritable bowel syndrome
-
Horwitz BJ, Fisher RS: The irritable bowel syndrome. N Engl J Med 344:1846-1850, 2001
-
(2001)
N Engl J Med
, vol.344
, pp. 1846-1850
-
-
Horwitz, B.J.1
Fisher, R.S.2
-
3
-
-
0033672548
-
Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population
-
Kennedy TM, Jones RH: Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population. Br J Surg 87:1658-1663, 2000
-
(2000)
Br J Surg
, vol.87
, pp. 1658-1663
-
-
Kennedy, T.M.1
Jones, R.H.2
-
4
-
-
0038030622
-
Systematic review: Abdominal and pelvic surgery in patients with irritable bowel syndrome
-
Hasler WL, Schoenfeld P: Systematic review: Abdominal and pelvic surgery in patients with irritable bowel syndrome. Aliment Pharmacol Ther 17:997-1005, 2003
-
(2003)
Aliment Pharmacol Ther
, vol.17
, pp. 997-1005
-
-
Hasler, W.L.1
Schoenfeld, P.2
-
5
-
-
0004048238
-
-
East Hanover, NJ, Novartis
-
Novartis: Zelnorm [package insert]. East Hanover, NJ, Novartis, 2002
-
(2002)
Zelnorm [Package Insert]
-
-
-
6
-
-
0036254583
-
Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms
-
Fidelholtz J, Smith W, Rawls J, et al.: Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms. Am J Gastroenterol 97:1176-1181, 2002
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 1176-1181
-
-
Fidelholtz, J.1
Smith, W.2
Rawls, J.3
-
7
-
-
0037799916
-
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
-
Kellow J, Lee OY, Chang FY, et al.: An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut 52:671-676, 2003
-
(2003)
Gut
, vol.52
, pp. 671-676
-
-
Kellow, J.1
Lee, O.Y.2
Chang, F.Y.3
-
8
-
-
0034794595
-
Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation
-
Muller-Lissner SA, Fumagalli I, Bardhan KD, et al.: Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 15:1655-1666, 2001
-
(2001)
Aliment Pharmacol Ther
, vol.15
, pp. 1655-1666
-
-
Muller-Lissner, S.A.1
Fumagalli, I.2
Bardhan, K.D.3
-
9
-
-
0036829638
-
A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation
-
Novick J, Miner P, Krause R, et al.: A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 16:1877-1888, 2002
-
(2002)
Aliment Pharmacol Ther
, vol.16
, pp. 1877-1888
-
-
Novick, J.1
Miner, P.2
Krause, R.3
-
10
-
-
0029080681
-
Use of insurance claims in epidemiologic research: Identification of peptic ulcers, GI bleeding, pancreatitis, hepatitis and renal disease
-
Lanza LL, Dreyer NA, Schulz NJ, Walker AM: Use of insurance claims in epidemiologic research: Identification of peptic ulcers, GI bleeding, pancreatitis, hepatitis and renal disease. Pharmacoepidemiol Drug Saf 4:239-248, 1995
-
(1995)
Pharmacoepidemiol Drug Saf
, vol.4
, pp. 239-248
-
-
Lanza, L.L.1
Dreyer, N.A.2
Schulz, N.J.3
Walker, A.M.4
-
11
-
-
0027616341
-
Using claims data for epidemiologic research. The concordance of claims-based criteria with the medical record and patient survey for identifying a hypertensive population
-
Quam L, Ellis LB, Venus P, Clouse J, Taylor CG, Leatherman S: Using claims data for epidemiologic research. The concordance of claims-based criteria with the medical record and patient survey for identifying a hypertensive population. Med Care 31:498-507, 1993
-
(1993)
Med Care
, vol.31
, pp. 498-507
-
-
Quam, L.1
Ellis, L.B.2
Venus, P.3
Clouse, J.4
Taylor, C.G.5
Leatherman, S.6
-
13
-
-
30844440693
-
-
Bethesda, Md. Philadelphia, PA, American Society of Health-System Pharmacists, Lippincott Williams & Wilkins
-
American Society of Health-System Pharmacists: AHFS Drug Handbook. Bethesda, Md. Philadelphia, PA, American Society of Health-System Pharmacists, Lippincott Williams & Wilkins, 2002, pp ix, 1349
-
(2002)
AHFS Drug Handbook
-
-
-
15
-
-
0003898553
-
-
Bethesda, Md. Washington, DC: U.S. Department of Health Education and Welfare, Public Health Service, National Institutes of Health
-
Rothman KJ, Boice JD: Epidemiologic analysis with a programmable calculator. Bethesda, Md. Washington, DC: U.S. Department of Health Education and Welfare, Public Health Service, National Institutes of Health, 1979, pp vii, 142
-
(1979)
Epidemiologic Analysis with a Programmable Calculator
-
-
Rothman, K.J.1
Boice, J.D.2
-
16
-
-
0003526332
-
-
Cary, NC, SAS Institute
-
Stokes ME, Davis CS, Koch GG: Categorical Data Analysis Using the SAS System. Cary, NC, SAS Institute, 2000, viii, p 626
-
(2000)
Categorical Data Analysis Using the SAS System
, vol.8
, pp. 626
-
-
Stokes, M.E.1
Davis, C.S.2
Koch, G.G.3
-
17
-
-
0033212831
-
Irritable bowel syndrome: Definition, diagnosis and epidemiology
-
Talley NJ: Irritable bowel syndrome: definition, diagnosis and epidemiology. Baillieres Best Pract Res Clin Gastroenterol 13:371-384, 1999
-
(1999)
Baillieres Best Pract Res Clin Gastroenterol
, vol.13
, pp. 371-384
-
-
Talley, N.J.1
-
18
-
-
2942587232
-
Irritable bowel syndrome and surgery: A multivariable analysis
-
Longstreth GF, Yao JF: Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 126:1665-1673, 2004
-
(2004)
Gastroenterology
, vol.126
, pp. 1665-1673
-
-
Longstreth, G.F.1
Yao, J.F.2
-
19
-
-
3042581462
-
Evidence-based position statement on the management of irritable bowel syndrome in North America
-
Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol 97:S1-S5, 2002
-
(2002)
Am J Gastroenterol
, vol.97
-
-
-
20
-
-
1942440353
-
Occurrence of colon ischemia in relation to irritable bowel syndrome
-
Cole JA, Cook SF, Sands BE, Ajene AN, Miller DP, Walker AM: Occurrence of colon ischemia in relation to irritable bowel syndrome. Am J Gastroenterol 99:486-491, 2004
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 486-491
-
-
Cole, J.A.1
Cook, S.F.2
Sands, B.E.3
Ajene, A.N.4
Miller, D.P.5
Walker, A.M.6
|